Advisory service on English disclosure of annual reports, financial statements and financial statements disclosed by listed company in Prime market (pharmaceutical industry, sales of JPY 10 billion or more). The client prepares the English text (based on the previous year) initially, and we prepared the English text for the revised parts and new text, as well as proofreading. In addition to the English text, we also handle a wide range of typographical errors in the Japanese language on a noticed basis.